查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1850564

獸醫參考實驗室市場：按動物類型、檢測類型、技術、最終用戶、疾病類型和樣本類型 - 2025-2032 年全球預測

Veterinary Reference Laboratory Market by Animal Type, Test Type, Technology, End User, Disease Type, Sample Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫參考實驗室市場將成長 136.6 億美元，複合年成長率為 14.20%。

主要市場統計數據
基準年2024年 47.2億美元
預計2025年 53.9億美元
預測年份：2032年 136.6億美元
複合年成長率（%） 14.20%

介紹重點介紹技術進步、監管發展和商業壓力如何重新定義獸醫診斷實驗室的優先事項

介紹部分描繪了快速發展的獸醫診斷領域，其中技術創新、不斷變化的監管環境以及動物健康的變化正在重塑實驗室操作和臨床決策。

在獸醫實務和公共衛生領域，診斷正成為實證醫療的核心組成部分。實驗室正在採用靈敏的分子檢測法，以及更成熟的免疫檢測和培養方法，以滿足臨床醫生對更快、更準確結果的需求。同時，資源限制和供應鏈複雜性也對常規檢測吞吐量提出了挑戰。本概述將重點討論如何重新配置​​診斷路徑、相關人員如何調整實驗室工作流程以及如何將診斷數據整合到疾病監測和預防保健計劃中。本文也重點介紹了臨床需求、實驗室能力和外部壓力如何相互作用，從而為獸醫參考實驗室創造商業機會和營運壓力點。

後續章節將以此為基礎，揭示市場的結構動態、監管和貿易影響、細分考慮、區域模式、競爭行為以及為領導者提供實用建議，幫助他們應對短期中斷，同時使其組織保持持續的臨床相關性和營運彈性。

對技術、監管和供應鏈融合力量的權威分析，這些力量正在加速動物診斷服務的結構性變革

本節探討重塑獸醫診斷服務的變革性變化，重點關注技術進步、政策變化和不斷變化的相關人員期望，這些正在加速獸醫診斷服務的成熟。

分子診斷已超越細分應用領域，成為臨床檢測的核心支柱，以前所未有的速度實現病原體特異性鑑定、抗藥性分析和疫情追蹤。同時，質譜和高通量免疫檢測的進步擴展了實驗室代謝和荷爾蒙評估的工具箱。法律規範正在適應這些技術，更新驗證途徑和品質要求，以促進標準化，但也使合規性變得更加複雜。在系統層面，診斷結果與實踐管理和流行病學平台的數位整合正在改變臨床決策，並支持人群層面的監測。此外，籌資策略正轉向更具韌性的供應鏈，買家傾向於採用多供應商模式和本地製造夥伴關係關係，以減輕跨境中斷的影響。總而言之，這些趨勢正在加速服務提供者之間的整合，同時擴大專業實驗室和技術整合商佔領新臨床利基市場的範圍。最終的結果是建立一個更複雜、互聯互通的診斷生態系統，獎勵卓越的營運、數據管治以及與臨床醫生需求的策略協調。

深入回顧美國近期的關稅調整如何重塑診斷實驗室的採購、供應鏈彈性和營運規劃

該分析檢視了近期美國關稅變化對獸醫診斷業務、供應鏈和籌資策略的累積影響，同時對營運現實和緩解方法保持平衡的觀點。

關稅波動給支持常規和先進診斷方法的消耗品和資本設備都帶來了成本壓力。實驗室正在透過重新評估其供應商組合、協商長期合約和實施庫存最佳化措施來應對，以減少其受價格波動的影響。同時，一些實驗室正在透過調整測試選單和優先內部開發試劑和通訊協定來減少對進口的依賴。對於設備採購，採購團隊擴大將總擁有成本（包括關稅風險和定序物流）納入其資本論證模型。法規遵循考慮使供應商替代變得複雜，並鼓勵在實施替代方案時採用更有條理的驗證和交叉反應測試方法。重要的是，關稅摩擦也推動了區域採購和與願意共同開發客製化解決方案的國內製造商的策略夥伴關係。在這種環境下，實驗室領導者必須平衡短期成本控制和長期投資，以保持臨床能力和服務可靠性。

以整體、細分主導導向的觀點，將動物類別、診斷方式、技術平台、最終用戶需求、疾病重點和檢體類型與實驗室策略聯繫起來

細分主導的洞察揭示了診斷需求和實驗室設計如何因動物類別、測試方式、技術平台、最終用戶類型、疾病重點和檢體流程而異，為投資組合和產能規劃提供了詳細的圖表。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 實施人工智慧驅動的診斷平台，用於跨多物種樣本的通用感染疾病的早期檢測
  • 採用液態生物檢體技術監測小型和大型動物的癌症生物標記
  • 擴大多重PCR檢測，實現同時檢測牲畜多種感染疾病
  • 整合基於區塊鏈的可追溯系統以確保獸醫診斷中的樣本來源
  • 利用元基因組定序全面監測獸醫病原體中新出現的抗生素抗藥性模式
  • 引入雲端基礎的數據分析儀表板，用於即時監測動物健康疫情

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 獸醫參考實驗室市場（依動物類型）

  • 大型動物
    • 牛
    • 馬
  • 小寵物
    • 貓
    • 狗

9. 獸醫參考實驗室市場（依測試類型）

  • 微生物學
  • 分子診斷
  • 病理
  • 血清學

10. 獸醫參考實驗室市場（依技術）

  • 傳統的
  • 免疫檢測
  • 質譜法
  • 分子

第 11 章獸醫參考實驗室市場（按最終用戶）

  • 學術的
  • 商業的
  • 政府

第12章 獸醫參考實驗室市場（依疾病類型）

  • 遺傳性疾病
  • 荷爾蒙
  • 感染疾病
    • 細菌
    • 真菌
    • 寄生蟲
    • 病毒性的
  • 代謝

13. 獸醫參考實驗室市場（依樣本類型）

  • 血
  • 屎
  • 棉花棒
  • 組織
  • 尿

14. 獸醫參考實驗室市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章獸醫參考實驗室市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 獸醫參考實驗室市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Covetrus, Inc.
    • Heska Corporation
    • Neogen Corporation
    • Eurofins Scientific SE
    • SYNLAB AG
Product Code: MRR-374DB5A06893

The Veterinary Reference Laboratory Market is projected to grow by USD 13.66 billion at a CAGR of 14.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.72 billion
Estimated Year [2025] USD 5.39 billion
Forecast Year [2032] USD 13.66 billion
CAGR (%) 14.20%

A focused introduction that sets the context for how technological advances, regulatory dynamics, and operational pressures are redefining veterinary diagnostic laboratory priorities

The introduction frames a rapidly evolving veterinary diagnostic landscape where technological innovation, shifting regulatory priorities, and changing patterns of animal health converge to reshape laboratory operations and clinical decision making.

Across veterinary practice and public health functions, diagnostics are increasingly central to evidence-based care. Laboratories are adopting high-sensitivity molecular assays alongside more established immunoassays and culture-based techniques to meet clinician demands for faster, more precise results. At the same time, resource constraints and supply chain complexity challenge routine testing throughput. This introductory overview sets the stage for a focused examination of how diagnostic pathways are being reconfigured, how stakeholders are adapting laboratory workflows, and how diagnostic data are being integrated into disease surveillance and preventive care programs. It also highlights the interplay between clinical needs, laboratory capabilities, and external pressures that create both opportunities and operational stress points for veterinary reference laboratories.

Subsequent sections build from this foundation to unpack structural market dynamics, regulatory and trade impacts, segmentation-driven insights, regional patterns, competitive behaviors, and practical recommendations for leaders seeking to navigate near-term disruptions while positioning their organizations for sustained clinical relevance and operational resilience.

An authoritative analysis of the converging technological, regulatory, and supply chain forces that are accelerating structural change across veterinary diagnostic services

This section examines transformative shifts reshaping veterinary diagnostic services, emphasizing technological progress, policy change, and evolving stakeholder expectations that together accelerate the sector's maturation.

Molecular diagnostics have moved beyond niche applications to become a core pillar of clinical testing, enabling pathogen-specific identification, resistance profiling, and outbreak tracing with unprecedented speed. Concurrently, advances in mass spectrometry and high-throughput immunoassays have expanded the laboratory toolbox for metabolic and hormonal assessments. Regulatory frameworks are adapting to these technologies with updated validation pathways and quality requirements that drive standardization but also increase compliance complexity. At the systems level, digital integration of diagnostic results into practice management and epidemiological platforms is changing the cadence of clinical decision making and supporting population-level surveillance. Moreover, procurement strategies are shifting toward resilient supply chains, with buyers favoring multi-supplier approaches and local manufacturing partnerships to mitigate cross-border disruptions. Taken together, these forces are accelerating consolidation among service providers while opening space for specialized laboratories and technology integrators to capture new clinical niches. The net effect is a more sophisticated, interconnected diagnostic ecosystem that rewards operational excellence, data governance, and strategic alignment with clinician needs.

A detailed review of how recent tariff adjustments in the United States are reshaping procurement, supply chain resilience, and operational planning for diagnostic laboratories

This analysis explores the cumulative effects of recent tariff changes in the United States on veterinary diagnostic operations, supply chains, and procurement strategies while preserving a balanced view of operational realities and mitigation approaches.

Tariff shifts have introduced cost pressure across both consumables and capital equipment that support routine and advanced diagnostic modalities. Laboratories have responded by re-evaluating supplier portfolios, negotiating longer-term contracts, and implementing inventory optimization measures to reduce exposure to price volatility. In parallel, some organizations are adjusting test menus and prioritizing in-house development of reagents and protocols to reduce dependency on imported inputs. For equipment acquisitions, procurement teams are increasingly factoring total cost of ownership, including tariff risk and servicing logistics, into capital justification models. Regulatory compliance considerations complicate supplier substitution, encouraging a methodical approach to validation and cross-reactivity testing when alternatives are introduced. Importantly, tariff-induced friction has also incentivized regional sourcing and strategic partnerships with domestic manufacturers willing to co-develop bespoke solutions. In this environment, laboratory leaders must balance short-term cost containment with long-term investments that preserve clinical capabilities and service reliability, recognizing that operational continuity remains essential for animal health care and public health surveillance.

A comprehensive segmentation-driven perspective that links animal categories, diagnostic modalities, technology platforms, end-user needs, disease focuses, and specimen types to laboratory strategy

Segmentation-driven insight reveals how diagnostic demand and laboratory design vary by animal category, test modality, technology platform, end-user type, disease focus, and sample stream, offering a granular map for portfolio and capability planning.

Based on animal type, analytical pathways diverge between Large Animals, which prioritize production and herd health considerations and are studied across Cattle and Horses, and Small Companion Animals, which prioritize individual clinical outcomes and are studied across Cats and Dogs. Based on test type, laboratory services span Microbiology, Molecular Diagnostics, Pathology, and Serology, each with distinct workflow, turnaround time, and quality control imperatives. Based on technology, choices range across Conventional methods, Immunoassay platforms, Mass Spectrometry approaches, and Molecular tools, shaping capital needs and staffing competencies. Based on end user, demand originates from Academic institutions, Commercial practices, and Government laboratories, each bringing different expectations for reporting, validation, and research collaboration. Based on disease type, diagnostics address Genetic Disorders, Hormonal conditions, Infectious Diseases, and Metabolic issues, with Infectious Diseases further studied across Bacterial, Fungal, Parasitic, and Viral categories that imply differing sample handling and biosafety standards. Based on sample type, analytical pipelines are calibrated for Blood, Feces, Swabs, Tissue, and Urine, with pre-analytic controls and transport logistics tailored to preserve analyte integrity. Integrating these segmentation lenses enables laboratory leaders to align test menus, instrument footprints, staffing models, and client engagement strategies with clinical demand and operational constraints.

A nuanced regional analysis highlighting how regulatory diversity, clinical adoption patterns, and supply chain structures uniquely shape laboratory operations across global territories

Regional patterns demonstrate distinct regulatory, supply, and clinical practice contexts that influence laboratory operations and strategic positioning across global markets.

In the Americas, diagnostic networks are increasingly consolidated, with a strong emphasis on integrated laboratory information systems and partnerships between clinical practices and centralized reference services; this region often leads in clinical adoption of advanced molecular assays and rapid-response capabilities. In Europe, Middle East & Africa, regulatory harmonization efforts and diverse public health priorities create a mosaic of laboratory requirements, where multilingual reporting, cross-border collaboration, and variable infrastructure levels demand flexible service models. In the Asia-Pacific region, rapid growth in pet ownership and intensifying livestock production are driving demand for scalable diagnostic solutions, while local manufacturing and innovative distribution channels are reshaping procurement dynamics. Each regional context carries its own talent pool considerations, reimbursement norms, and logistical challenges, suggesting that a one-size-fits-all approach to service design is likely to underperform. Instead, tailored regional strategies that account for regulatory timing, supply chain topology, and clinician expectations will better support sustainable expansion and quality outcomes.

An insightful overview of the strategic postures adopted by industry participants, from vertically integrated platforms to specialist service providers and collaborative innovation models

Competitive behaviors among leading companies illustrate how strategic choices around vertical integration, service breadth, and partnership models create differentiated value propositions in the diagnostic ecosystem.

Some firms are concentrating on building comprehensive end-to-end offerings that combine proprietary assays, instrument platforms, and managed services to create stickier customer relationships and predictable revenue streams. Others pursue a modular approach, focusing on specialty testing or technology-enabled services that integrate with third-party laboratory information systems to deliver flexibility for clinicians. Strategic alliances with academic centers and government programs continue to be important channels for validation studies and product adoption, particularly for novel molecular and genomic applications. Investment in quality systems, accreditation, and transparent clinical performance data serves as a key trust signal for clients that demand rigorous evidence of diagnostic reliability. Additionally, companies are increasingly leveraging data analytics and remote monitoring to offer value-added services such as test utilization reviews and population health insights. This competitive heterogeneity creates opportunities for both consolidation and niche specialization, with successful organizations combining technical excellence with strong client engagement and operational reliability.

Action-oriented guidance for laboratory leadership focused on workforce agility, procurement resilience, modular technology adoption, and evidence-driven partnerships to secure long-term operational strength

Actionable recommendations guide laboratory executives and industry leaders on prioritizing investments, workforce development, and supplier strategies to strengthen resilience and clinical relevance.

Leaders should invest in cross-trained laboratory personnel who can operate molecular instruments, mass spectrometers, and immunoassay platforms while maintaining strong quality assurance practices; such capability reduces bottlenecks and enhances flexibility during demand surges. Procurement strategies should emphasize supplier diversification, strategic stocking of critical reagents, and collaborative agreements with local manufacturers to reduce tariff and logistics exposure. From a technology standpoint, adopting modular, interoperable systems and standardized data exchange protocols improves scalability and eases integration with clinical practice management tools. Strategic partnerships with academic centers and public health agencies can accelerate validation pathways and expand the clinical evidence base for new assays. Finally, governance frameworks that prioritize data integrity, client communication, and transparent performance metrics will help build trust with clinicians and regulatory bodies, supporting sustained laboratory relevance amid evolving clinical and policy expectations.

A transparent and rigorous research methodology combining primary stakeholder engagement and targeted secondary evidence synthesis to produce defensible operational insights

The research methodology section describes the structured approach used to gather, validate, and synthesize qualitative and quantitative inputs from a broad range of stakeholders for a rigorous, reproducible analysis.

Primary research included in-depth interviews and structured consultations with laboratory directors, clinicians, procurement specialists, and regulatory advisors to capture frontline experience with diagnostic workflows, technology adoption, and supply chain challenges. Secondary sources comprised peer-reviewed literature, regulatory guidance documents, and industry reports to provide contextual grounding and to triangulate primary insights. Data synthesis employed thematic analysis to identify cross-cutting patterns and causal linkages, while validation rounds with subject-matter experts ensured that findings were operationally relevant and technically accurate. Attention was given to transparency in assumptions and to documenting methodological limitations, particularly where regional data heterogeneity required careful interpretation. The result is a defensible, practice-focused body of work that supports strategic decision making without overstating precision in areas where data are fragmented or rapidly evolving.

A strategic conclusion that crystallizes the essential operational and clinical imperatives laboratories must adopt to remain resilient, credible, and service-focused in a changing environment

The conclusion synthesizes the study's core implications for diagnostic strategy, operational resilience, and clinical impact, reinforcing the imperative for proactive leadership across laboratory networks.

Diagnostic services sit at the intersection of animal health, public health surveillance, and clinical care, and the sector's trajectory is shaped by technological innovation, regulatory evolution, and supply chain dynamics. Organizations that align capabilities with segmentation realities-matching test menus and platforms to animal type, disease focus, and sample workflows-are better positioned to deliver timely, actionable results. Strategic investments in workforce skills, interoperable technologies, and diversified procurement reduce operational fragility and enable laboratories to respond to episodic surges or supply disruptions. Collaborative relationships with academic, commercial, and governmental partners can accelerate method validation and broaden the evidence base for new assays. In closing, the path to sustained relevance depends on deliberate, evidence-based choices that balance near-term continuity with long-term capability building, ensuring that diagnostic services remain a reliable foundation for clinical decision making and disease prevention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of AI-driven diagnostic platforms for early detection of zoonotic pathogens across multi-species samples
  • 5.2. Adoption of liquid biopsy techniques to monitor cancer biomarkers in small and large animal patients
  • 5.3. Expansion of multiplex PCR assays enabling simultaneous detection of multiple infectious diseases in livestock
  • 5.4. Integration of blockchain-based traceability systems to secure sample provenance in veterinary diagnostics
  • 5.5. Use of metagenomic sequencing for comprehensive surveillance of emerging antimicrobial resistance patterns in veterinary pathogens
  • 5.6. Deployment of cloud-based data analytics dashboards for real-time epidemiological monitoring of animal health outbreaks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Reference Laboratory Market, by Animal Type

  • 8.1. Large Animals
    • 8.1.1. Cattle
    • 8.1.2. Horses
  • 8.2. Small Companion Animals
    • 8.2.1. Cats
    • 8.2.2. Dogs

9. Veterinary Reference Laboratory Market, by Test Type

  • 9.1. Microbiology
  • 9.2. Molecular Diagnostics
  • 9.3. Pathology
  • 9.4. Serology

10. Veterinary Reference Laboratory Market, by Technology

  • 10.1. Conventional
  • 10.2. Immunoassay
  • 10.3. Mass Spec
  • 10.4. Molecular

11. Veterinary Reference Laboratory Market, by End User

  • 11.1. Academic
  • 11.2. Commercial
  • 11.3. Government

12. Veterinary Reference Laboratory Market, by Disease Type

  • 12.1. Genetic Disorders
  • 12.2. Hormonal
  • 12.3. Infectious Diseases
    • 12.3.1. Bacterial
    • 12.3.2. Fungal
    • 12.3.3. Parasitic
    • 12.3.4. Viral
  • 12.4. Metabolic

13. Veterinary Reference Laboratory Market, by Sample Type

  • 13.1. Blood
  • 13.2. Feces
  • 13.3. Swabs
  • 13.4. Tissue
  • 13.5. Urine

14. Veterinary Reference Laboratory Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Reference Laboratory Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Reference Laboratory Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Covetrus, Inc.
    • 17.3.4. Heska Corporation
    • 17.3.5. Neogen Corporation
    • 17.3.6. Eurofins Scientific S.E.
    • 17.3.7. SYNLAB AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY REFERENCE LABORATORY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY REFERENCE LABORATORY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2024